Morepen Laboratories Ltd. published its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2024, reporting total income from operations of ₹43,772.61 lakhs, net profit after tax of ₹3,484.56 lakhs, and earnings per share of ₹0.65. The results were approved by the Board of Directors on November 11, 2024, and published in Financial Express and Jansatta newspapers.